Shares of Madrigal Pharmaceuticals Inc. MDGL, +268.07% soared 209.6% in premarket trading on Monday after the company shared positive data from a pivotal Phase 3…
breakingnow_w51jcqDecember 20, 2022
MarketsHeard on the StreetBetter-than-expected results for company’s NASH treatment could rekindle big pharma interest in this disease area Read the original article
breakingnow_w51jcqDecember 19, 2022
